Stroke with Forehead Paralysis: Critical Diagnostic and Management Approach
Key Distinction: This Indicates Central (Upper Motor Neuron) Facial Palsy
Forehead paralysis in a stroke patient signifies involvement of the upper face, which is the hallmark of a central (cortical or subcortical) lesion rather than a peripheral facial nerve problem—this demands immediate comprehensive stroke evaluation and aggressive management. 1, 2
The presence of forehead involvement (inability to wrinkle forehead, raise eyebrows, or close eyes completely) indicates a lower motor neuron pattern, which paradoxically suggests either:
- A pontine/brainstem stroke affecting the facial nucleus or nerve fascicle 3, 4
- Flow-limiting middle cerebral artery (MCA) disease 5
Critical Neurological Findings to Assess Immediately
Perform Standardized NIHSS Examination
Use the National Institutes of Health Stroke Scale to systematically evaluate: 1, 2, 6
Cranial Nerve Assessment:
- Gaze abnormalities (0=normal, 1=partial gaze palsy, 2=forced deviation) 1, 2
- Visual field defects (hemianopia, quadrantanopia, extinction) 1, 2
- Complete facial palsy grading (0=normal, 1=minor asymmetry, 2=partial lower face, 3=complete upper and lower face paralysis) 1, 2
Motor Function:
- Arm drift/weakness bilaterally (test at 90° sitting or 45° supine for 10 seconds) 1, 2
- Leg drift/weakness bilaterally (test at 30° for 5 seconds) 1, 2
- Grade: 0=no drift, 1=drift, 2=some antigravity, 3=no antigravity, 4=no movement 1, 2
Coordination and Sensation:
- Limb ataxia (finger-to-nose, heel-to-shin) 1, 2
- Sensory loss (unilateral vs bilateral, mild vs severe) 1, 2
Language and Cognition:
- Aphasia (expressive, receptive, or global) 1, 2
- Dysarthria (slurred speech) 1, 2
- Neglect/extinction to double simultaneous stimulation 1, 2
- Level of consciousness (alert, drowsy, obtunded, coma) 1, 2
Specific Red Flags for Pontine/Brainstem Involvement
When facial palsy includes forehead involvement, actively search for: 3, 4
- Conjugate gaze palsy (inability to look toward the side of lesion) 4
- Gaze-evoked nystagmus 4
- Vertigo or severe dizziness 4
- Cerebellar signs: truncal ataxia, broad-based gait, dysmetria 4
- Contralateral hemiparesis (if ventral pons involved) 3
- Altered consciousness disproportionate to imaging 7
Vascular Territory Localization
If isolated facial palsy with forehead involvement: 5
- 78% have flow-limiting mid-to-distal M1 or proximal M2 MCA disease 5
- Only 22% have traditional lacunar lesions (corona radiata or pons) 5
- Look for prominent early anterior temporal artery on imaging 5
Immediate Management Algorithm
Acute Stabilization (First 30 Minutes)
Airway and Breathing: 2
- Assess for airway compromise from decreased consciousness or brainstem dysfunction 2
- Monitor oxygen saturation continuously (target >94%) 2
- Position head of bed 20-30° if no hypoxia to optimize cerebral perfusion 2
- Document blood pressure (severe elevation >220 mmHg suggests hemorrhage or hypertensive encephalopathy) 6
- Check for irregular pulse (atrial fibrillation) 6
- Measure temperature every 4 hours for first 48 hours 7
Swallowing Precautions: 7
- Keep patient NPO until validated swallowing screen completed 7
- High aspiration risk with brainstem involvement 6
Diagnostic Workup
Immediate Imaging (within 25 minutes of arrival): 2
- Non-contrast CT head to exclude hemorrhage 2
- If CT negative but high suspicion: MRI with diffusion-weighted imaging (more sensitive for pontine infarcts) 3, 4
- CT angiography or MR angiography of head and neck to identify vessel occlusion/stenosis 2, 5
- Glucose, electrolytes, complete blood count 7
- PT/INR, aPTT (especially if on anticoagulants) 2, 7
- Troponin and ECG (cardiac source) 2
Thrombolytic Eligibility Assessment
Time-Critical Decision (within 60 minutes): 1
- Establish exact time last known normal (not time found with symptoms) 6
- If within 3-4.5 hour window and no contraindications, consider IV tPA 1
- NIHSS score helps predict hemorrhage risk and outcome 6
Contraindications to assess: 6
- Active bleeding, recent surgery/trauma 6
- Current anticoagulation (INR >1.7) 6
- Severe hypertension (>185/110 mmHg) 6
Management of Acute Complications
Seizure Management (if occurs)
Do NOT use prophylactic anticonvulsants 7
- Prophylaxis impairs neural recovery and cognitive function 7
- No benefit in preventing post-stroke seizures 7
If seizure occurs: 7
- First-line: Lorazepam 4 mg IV at 2 mg/min 7
- Second-line: Levetiracetam 30 mg/kg IV over 5 minutes (not maintenance doses of 500-1000 mg) 7
- Avoid phenytoin due to worse cognitive outcomes 7
Monitoring: 7
- Assess for seizure activity at each vital sign check 7
- Consider continuous EEG for 24-48 hours if consciousness disproportionately reduced 7
Cerebral Edema (peaks at 3-5 days)
Risk factors: 6
Management: 6
- Mild fluid restriction, avoid hypoosmolar fluids (5% dextrose) 6
- Treat hypoxia, hypercarbia, hyperthermia 6
- Elevate head of bed 20-30° 6
- Avoid antihypertensives that cause cerebral vasodilation 6
Infection Prevention
Pneumonia (leading cause of post-stroke death): 6
- Early mobilization when safe 6
- Aspiration precautions until swallow screen passed 6
- Prompt antibiotic therapy if fever develops 6
Deep Vein Thrombosis: 6
- Subcutaneous anticoagulants or intermittent pneumatic compression 6
- Aspirin if anticoagulants contraindicated 6